Experimental Study on Inhibitory Effects of Diallyl Sulfide on Growth and Invasion of Human Osteosarcoma MG-63 Cells

The inhibitory effects of diallyl sulfide(DAS) derived from allicin on in vitro and in vivo proliferation of human osteosarcoma MG-63 cells and the action mechanism,and the influence of DAS on invasive capability of MG-63 cells were investigated in order to search for the novel medicines for osteosarcoma.In the in vitro experiment,MG-63 cells were treated with different concentrations of DSA,and the morphological changes of MG-63 cells were observed under an inverted phase microscope.MTT method was used to assay the proliferation of MG-63 cells.Semi-quantitative reverse transcription polymerase chain reaction(RT-PCR) was used to detect the VEGF mRNA expression level in MG-63 cells.By using Transwell invasion assay,the influence of DAS on invasive ability of MG-63 cells was tested.In the in vivo experiment,the nude mice MG-63 cells tumor-bearing model was established,and different concentrations of DAS were injected beside the tumor.Twenty-one days after treatment,the mice were killed,the tumor size and tumor inhibition rate were calculated.The microvessel density(MVD) was determined by using immunohistochemistry.In the in vitro experiment,different concentrations of DAS could obviously inhibit proliferation of MG-63 cells in a time-and concentration-dependent manner.RT-PCR revealed that the expression levels of VEGF mRNA in DSA groups(different concentrations) were significant reduced as compared with those in control group(all P<0.05).Transwell invasion assay indicated that in 20 and 40 μg/mL DAS groups,the number of migratory cells was 91.4±8.3 and 81.8±7.4 respectively,which was significantly declined as compared with that in control group(150.4±14.7,both P<0.05).In the in vivo experiment,DAS could significantly suppress the growth of MG-63 tumor-bearing tissue.Immunohistochemistry demonstrated that different concentrations(20 and 40 μg/mL) of DAS could significantly decrease MVD of MG-63 tumor-bearing tissue(all P<0.05).It was suggested that DAS could inhibit the growth of MG-63 cells probably by suppressing the expression of VEGF mRNA.

Vibramycin inhibits the expression of MMP-2 and the invasiveness of PC-3 cells in vitro

Objective To study the inhibition of vibramycin on the expression of matrix metalloproteinase-2 (MMP-2) and the invasiveness of androgen-independent prostatic carcinoma cell line PC - 3 in vitro. Methods Immunohistochemistry stain and transwell chamber were used to investigate the expression of MMP-2 in different concentration of vibramycin treated PC-3 cells and the invasive ability of different concentration of vibramycin treated PC-3 cell. Results The positive rate of MMP-2 inJune 2003 Vol12 No2 PC-3 cells was decreased at a concentration of 5 mg/L of vibramycin and decreased dramatically at the concentration of 10 mg/L. The cells moved throuth the membrane was(82. 0 ± 4.6)/field in the control group, while decreased to(26.1 ±3.6),(7.2 ±2.2) and(3.3± 0.7)/field in 5,10 and 20 mg/L vibramycin treated PC-3 cell respectively. Conclusion Vibramycin can inhibit the invasiveness and metastatasis of PC-3 cells, the mechanism of which is related to the inhibition of MMP-2 in PC-3 cell.10refs.

Suppression of Growth of Hela, EJ, SK-OV-3 and MDA-MB-231 Cells by Recombinant Human NK4

Objective： To study the effects of recombinant human Nk4 on the growth and invasion activities of tumor cells. Methods： The inhibition of recombinant human NK4 on human oophoroma, cervical tumor, breast tumor and gallbladder tumor cells was evaluated in vitro by basement membrane invasion assay. Results： rhNK4 could markedly inhibited the growth of human oophoroma, cervical tumor and breast tumor cells. The inhibition rates of human oophoroma, cervical tumor, breast tumor and gallbladder tumor cells were 48.2%, 29.2%, 58.4% and 30.1% respectively. Conclusion： rhNK4 factor can markedly inhibit the invasion of multiple tumor cells.